6 results about "Eating disorders" patented technology

Methods of treating one or more eating disorders including anorexia nervosa, bulimia, and related clinical syndromes in a subject in need thereof are described. In some cases, electric stimulation and / or one or more active agents are administered to a subject in need thereof to reduce or inhibit the activity of CeA PKC-δ neurons and ovBNST PKC-δ neurons in the brain of the subject. Preferably, the disclosed methods are effective to increase or excite the activity of the brain regions downstream of CeA PKC-δ neurons and ovBNST PKC-δ neurons including medial part of CeA and ventral lateral part of BNST.

The invention concerns methods for treating unwanted body weight loss, and / or medically undesired body weight loss, or eating disorders (such as anorexia nervosa), by administration of a leptin receptor agonist, such as metreleptin. The invention also relates to methods for increasing body weight in a subject in need of the treatment.

Disclosed herein are aldehyde dehydrogenase (ALDH-2) inhibitor compounds, such as a compounds of Formula (I) or Formula (II), pharmaceutical compositions comprising these inhibitor compounds, and uses of these compounds and compositions, such as in the methods for safely treating chemical dependency on a substance or condition of addiction, such as alcohol, nicotine, cocaine, opiates, amphetamines, and compulsive eating disorder, and / or anxiety disorder, each individually or concurrent.

The application relates to an eating disorder intervention method and system based on a structured multi-module course, the method comprising: a user terminal sending a course access request to a server; the server obtaining a user course progress according to the course access request, determining a target course unit matched with the user course progress according to a course arrangement rule, searching for course unit data of the target course unit from a structured course database, and sending the course unit data to the user terminal; the user terminal presenting the course unit data of the target course unit to the user, guiding the user to perform an intervention task through an interactive interface, collecting corresponding structured user state data, and sending the collected user state data to the server; and the server judging whether a specified task of the target course unit is completed according to the user state data, updating the user course progress if the specified task is completed, and not updating the user course progress if the specified task is not completed. The application realizes forced guidance, standardized implementation and automatic management of a structured treatment process.

The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence / abuse / addiction and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.